TrialPloS one2018

First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1.

Kathryn E Stephenson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.